Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (KCT0012581) titled 'Clinical Study to Evaluate the Efficacy and Safety of Actiponin(R) on Joint and Cartilage health' on Sept. 8.

Study Type: Interventional Study

Study Design: Primary Purpose : Supportive Care, Intervention Model : Parallel, Blinding/Masking : Double, Blinding Target : Subject, Investigator, Allocation : RCT

Primary Sponsor: TG Biotech

Condition:

Diseases of the musculoskeletal system and connective tissue

Intervention: Dietary Supplement : Participants in the low-dose group will receive the test product containing 112.5 mg of Actiponin(R) (Gynostemma pentaphyllum extract powder), those in the high-dose group w...